Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Saturday, November 16, 2024 · 761,134,253 Articles · 3+ Million Readers

Antibody Drug Conjugates Market Size, Share Analysis, Trends And Drivers For 2023-2032

Antibody Drug Conjugates Market Report 2023

Antibody Drug Conjugates Market Report 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

LONDON, GREATER LONDON, UK, August 2, 2023/EINPresswire.com/ -- The Business Research Company’s “Antibody Drug Conjugates Global Market Report 2023” is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the antibody drug conjugates market size is predicted to reach $16.15 billion in 2027 at a CAGR of 22.4%.

The growth in the antibody drug conjugates targets market is due to rising incidences of cancer globally. North America region is expected to hold the largest antibody drug conjugates market share. Major antibody drug conjugates manufacturing companies include Bayer AG, Concortis Biotherapeutics, F. Hoffmann-La Roche Ltd., Immunomedics Inc., Oxford BioTherapeutics.

Antibody Drug Conjugates Market Segments
• By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Other Types
• By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications
• By Product: Adcertis, Kadcyla, Other Products
• By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology
• By End User: Hospital, Clinics, Other End Users
• By Geography: The global antibody drug conjugates market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

Antibody-drug conjugates (ADCs) refer to medications that are specifically designed to administer chemotherapy to cancer cells. ADCs deliver chemotherapy via a linker connected to a monoclonal antibody that binds to a specific target expressed on cancer cells.As soon as the ADC binds to its target (a cancer protein or receptor), a cytotoxic chemical is released into the cancer cell.

Read More On The Antibody Drug Conjugates Global Market Report At:
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Market Characteristics
3. Antibody Drug Conjugates Market Trends And Strategies
4. Antibody Drug Conjugates Market – Macro Economic Scenario
5. Antibody Drug Conjugates Market Size And Growth
……
27. Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:
Generic Pharmaceuticals Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceutical Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Branded Generics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire

Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release